Learn more about the role of Tuberculosis in cancer and how a simple vaccine supports the immune system to fight it.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Neil Vaccines are medicine which protect the human body by making it immune from a certain disease. Now, there’s been a sudden and important discovery – a breakthrough - in the development of a new ...

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

Personalized Cancer Vaccines Ecosystem Witnessing Positive Transition Driven By Development Of Proprietary Technology Platforms Says Kuick Research. Delhi, March 2 ...

Anixa Biosciences, Inc. (NASDAQ:ANIX) entered into a letter of intent with VERDI Solutions GmbH to develop personalized and ...

Anixa Biosciences signed a letter of intent with VERDI Solutions to develop AI-powered personalized and off-the-shelf cancer ...

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine. Anixa Biosciences, Inc. March 24, 2025.

New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the American Association for Cancer Research (AACR) ...

Thousands of women die from cervical cancer in the U.S. every year and cases are largely caused by HPV infection ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...